Yumanity Therapeutics closes $45mm Series A round
Yumanity Therapeutics (neurodegenerative disease therapeutics) raised $45mm in its Series A round led by Fidelity Management & Research Co. Other investors included Redmile Group (a participant in its 2015 seed funding), Alexandria Venture Investments, Biogen Inc., Sanofi-Genzyme BioVentures, and Dolby Family Ventures. One executive from Biogen and one from Alexandria joined the board.
Drug Discovery Tools
- Molecular Diversity
- Drug Discovery Tools
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.